anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

176,101-176,160 of 319,975

filter-aware
04
AgroFresh | Results Presentation Deck | 16 slidesAgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
05
The slide uses a table-like structure to map product categories to specific performance drivers.AgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
06
The slide uses a stacked bar chart for composition and a waterfall chart for growth attribution.AgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
07
The slide uses a stacked bar chart for category mix and a waterfall bridge chart for growth analysis.AgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
08
The slide uses a table-like layout to categorize performance drivers by region.AgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
The bridge chart illustrates the net change from $51.9M to $55.9M.AgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
10
The slide uses a stacked bar chart for regional mix and a waterfall bridge chart for growth decomposition.AgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
11
AgroFresh | Results Presentation Deck | 16 slidesAgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations 1 hit
12
Includes a bar chart showing Adjusted EBITDA trends and bulleted lists for financial highlights.AgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations 1 hit
13
Includes footnotes explaining specific financial adjustments and reconciliation references.AgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations 1 hit
14
AgroFresh | Results Presentation Deck | 16 slidesAgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations Beat · Action1 hit
15
AgroFresh | Results Presentation Deck | 16 slidesAgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations 1 hit
16
Includes footnotes explaining specific adjustments and the methodology for constant currency calculations.AgroFresh | Results Presentation Deck | 16 slides · AgroFresh Solutions, Inc.
Conference presentation Investor relations 1 hit
01
Slide 1
The slide uses a global map background to imply the scale of the mission.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
02
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
03
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
04
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
05
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · TeamLoop · Golden Circle1 hit
06
The slide uses a split-layout with a company mission statement on the left and product-specific details on the right.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
07
The slide highlights the lineage of the boron chemistry platform and the transition of assets from Anacor/Pfizer to AN2 Therapeutics.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
08
The slide uses a timeline-based roadmap structure to communicate clinical trial progress.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
09
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
10
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
11
Uses a Venn/concentric circle diagram to illustrate market segmentation.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a process flow to show the progression from treatment-naïve to refractory patients.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
13
Includes boxed warning information for a competitor/reference drug.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
14
Scientific diagram showing molecular binding interaction.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
MIC = Minimum Inhibitory Concentration. Data shows Epetraborole has lower MIC values compared to standard treatments.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
The chart highlights statistical significance between EBO doses and the CLR control.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
17
EBO = epetraborole, SoC = standard of care (clarithromycin, ethambutol, rifabutin).AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
18
Includes a timeline diagram of the study design and key clinical findings.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
19
The slide highlights the drug's targeted delivery to the site of infection (alveolar macrophages).AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
20
The slide outlines a seamless trial design with specific patient counts and milestones.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
21
Uses a concentric circle diagram to represent market segments and a map to show geographic reach.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
22
The table uses checkmarks and X marks to highlight competitive advantages of EBO.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
23
QIDP = Qualified Infectious Disease Product DesignationAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
24
Includes a timeline of clinical trials and a list of key investors.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
25
The slide highlights a focus on melioidosis and lists key research and funding partners.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
26
The slide uses a split-layout with a company mission statement on the left and product details on the right.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
27
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
01
Slide 1
Apexigen | SPAC Presentation Deck | 28 slidesApexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
02
Apexigen | SPAC Presentation Deck | 28 slidesApexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
03
Apexigen | SPAC Presentation Deck | 28 slidesApexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
04
Includes footnote regarding transaction expenses and equity line exclusion.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
05
Includes detailed footnotes regarding share calculations, redemption assumptions, and transaction costs.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
06
The slide uses a table-like layout to associate team members with their past company affiliations and a separate column for investor logos.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · Team1 hit
07
The slide uses a three-column layout for key business pillars supported by a central platform foundation.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a Gantt-style visualization to represent drug development progress across various therapeutic areas.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · Market Size1 hit
09
Apexigen | SPAC Presentation Deck | 28 slidesApexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
10
The slide uses a biological pathway diagram to illustrate the mechanism of action.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
Apexigen | SPAC Presentation Deck | 28 slidesApexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
The slide uses a funnel diagram to represent the clinical development strategy, emphasizing learning and de-risking.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · Product1 hit
13
The slide highlights a 'Single MoA Focus' on the right, emphasizing the mechanism of action for the combination therapies.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · Product1 hit
14
The slide uses two waterfall/spider plots to demonstrate efficacy in different clinical settings.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · Product1 hit
15
Includes study design, interim efficacy data, and a Kaplan-Meier survival curve comparison.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · Product1 hit
16
Includes study design flowchart, spider plot of tumor size changes, and summary statistics of patient responses.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
17
Apexigen | SPAC Presentation Deck | 28 slidesApexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
18
Apexigen | SPAC Presentation Deck | 28 slidesApexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
19
Apexigen | SPAC Presentation Deck | 28 slidesApexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit
20
The slide uses a biological process diagram to illustrate the mechanism of action.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank 1 hit